In Otolaryngology, CO2 or ENT laser surgery is frequently used to treat problems of the ear, nose, and throat. It is a minimally invasive surgery (MIS) that is completed quickly, with few complications, and with absolute accuracy. With a CAGR of 8.73%, laser technology is expanding rapidly and has become increasingly popular across the globe, particularly in the healthcare industry. In the United States, oral cancer is estimated to have caused 54000 diagnoses in 2020, about 9750 fatalities, or roughly one death per hour.
The market worth of ENT laser devices in 2021 was USD 117.5 million, and it will be worth USD 211.21 million by 2030, growing at a 6.73% CAGR during the forecast period.
The market for ENT laser devices is expanding due to the rising rate of hospitalizations due to sinusitis, tonsillitis, and throat and mouth cancer. As a result, hospitals are using ENT surgical and diagnostic equipment more frequently.
Hospitalizations for ENT conditions such as sinusitis, tonsillitis, sleep apnea, and throat and mouth cancer have increased due to the development of novel surgical methods. In addition, the increasing frequency of inflammatory illnesses of the ear, nose, and throat shows the need for cutting-edge treatment methods and technology. Due to this demand, a growing number of vendors are concentrating on extending their selection of ENT laser devices, which can boost market expansion.
The high expense of ENT procedures hampers the adoption of ENT laser technologies. The high cost of ENT laser equipment and ENT procedures may make them more expensive for patients and end-users, respectively. An ENT laser device typically costs between $4,500 and $35,000.
Cosmetic ENT surgeries are being performed frequently all over the world and will rise significantly. Nearly 13.3 million cosmetic minimally invasive operations will be carried out globally in 2020.
On the basis of product, the market for ENT laser devices is segmented into solid & semiconductor-based lasers and gas lasers. The gas lasers segment maintained the largest position in the market, with the largest share in 2020 due to the high efficiency rate in treating cancers.
On the basis of application, the market is segmented into tonsillitis, transoral laser microsurgery, throat & mouth cancer, sinusitis, and others. Throat & mouth cancer ruled the entire market due to its rising rate globally. In 2021, About 54,010 adult patients (38,800 males and 15,210 women) were identified to have oral and oropharyngeal cancer in the United States.
On the basis of end-user, the market is segmented into home care, hospitals & ambulatory surgical centers, and ENT clinics. Hospitals and ambulatory surgical centers held the biggest market share because ENT treatment, microvascular reconstruction, free muscle and bone transfers, free skin and skin fat transfers, greatly enhanced healthcare infrastructure, etc., are becoming more widely accessible.
North America contributed to the biggest market with a revenue share of 43% as a result of the rising incidence of cancer cases in noses, ears, and throats annually. Factors like the increasing need for a variety of laser treatments and growing developments in medical laser technology are contributing to the growth of this regional market. Europe is the second largest regional market for ENT laser devices due to greater healthcare expenditure.
- El.En. Spa
- ARC Laser GmbH
- Boston Scientific Corp
- Smith and Nephew plc
- IRIDEX Corp
- Limmer Laser GmbH
- Shanghai Fosun Pharmaceutical (Group) Co. Ltd.
- Lumenis Ltd
- Olympus Corp
- Sunny Optoelectronic Technology Co. Ltd
The market worth of ENT laser devices in 2021 was USD 117.5 million, and it will be worth USD 211.21 million by 2030, growing at a 6.73% CAGR during the forecast period. Technological developments in ENT surgery have increased the utilization of ENT laser devices. The rising incidence of ENT disorders is one of the major factors stimulating the growth of the market for ENT laser devices.